# Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma

> **NCT04066725** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 95 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DRUG:** Aspirin 81 mg
- **DRUG:** Aspirin 325mg
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04066725
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-25
- **Primary completion:** 2021-03-19
- **Final completion:** 2021-03-19
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066725, "Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04066725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*